Greenleaf Peter
CIK 0001363683
Chief Executive OfficerDirector
Filings
15
Latest Apr 6, 2026
Issuers covered
4
Showing
15 of 15
Page 1
Track record
8 of 8 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 8 | 25% | -9.5% | -11.9% | +8.5% | -21.7% |
| 90 days | 6 | 67% | +1.5% | +0.9% | +4.5% | -0.2% |
| 180 days | 6 | 17% | -13.6% | -11.7% | +35.4% | -46.4% |
| 365 days | 6 | 50% | -19.7% | -12.7% | +35.3% | -86.1% |
Issuers
Companies where Greenleaf Peter has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc. | 9 | Mar 3, 2026 |
| PTHS | Pelthos Therapeutics Inc. | 3 | Apr 6, 2026 |
| BDSI | Biodelivery Sciences International Inc | 2 | Mar 22, 2022 |
| ATRS | Antares Pharma, Inc. | 1 | May 26, 2022 |
All filings
15 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|